Clinical Trial Update: Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating CG200745 in combination with gemcitabine and erlotinib for advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neoplasms

Drugs mentioned

• CG200745
• ERLOTINIB (Erlotinib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: CrystalGenomics, Inc. | Conditions: Pancreatic Neoplasms | Phase 1, Phase 2 | Status: UNKNOWN